Shannon T. Kelley, General Counsel at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,204 shares at $372.44 ($809K) on 2025-08-18, disclosed to the SEC on 2025-08-18.
Scheduled sale ($809k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $358.66 | 458 | $164K | 20.3% |
| 2 | $358.66 | 458 | $164K | 20.3% |
| 3 | $369.64 | 126 | $47K | 5.8% |
| 4 | $370.06 | 84 | $31K | 3.8% |
| 5 | $371.35 | 84 | $31K | 3.9% |
| 6 | $372.44 | 252 |
| $94K |
| 11.6% |
| 7 | $372.44 | 252 | $94K | 11.6% |
| 8 | $374.13 | 68 | $25K | 3.1% |
| 9 | $375.75 | 190 | $71K | 8.8% |
| 10 | $375.75 | 190 | $71K | 8.8% |
| 11 | $376.62 | 42 | $16K | 2.0% |
| Total | $367.12 avg | 2,204 | $809K | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $344K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $139K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $151K | — | Filing → |